Chlorpheniramine MaleateThird Party Manufacturing in India

Chlorpheniramine Maleate works by competitively antagonising histamine at the H1 receptor site on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Histamine is a chemical mediator released by mast cells and basophils during allergic reactions that causes vasodilation, increased capillary permeability, bronchoconstriction, and stimulation of sensory nerve endings leading to itching and sneezing. By blocking the H1 receptor without activating it, Chlorpheniramine prevents histamine from binding and initiating this cascade of allergic symptoms. Unlike second-generation antihistamines, Chlorpheniramine readily crosses the blood-brain barrier, which accounts for its prominent sedative effect but also enhances its efficacy in managing symptoms that involve central pathways. The drug also exhibits weak anticholinergic and local anaesthetic properties at higher concentrations. Its onset of action is relatively rapid, with peak plasma concentrations achieved within two to six hours following oral administration, and the half-life extends to approximately 20 to 24 hours, providing sustained symptomatic relief. This makes Chlorpheniramine Maleate particularly effective for acute allergic episodes where rapid and reliable symptom control is needed, especially in seasonal allergic rhinitis and urticaria.

Therapeutic Uses

Chlorpheniramine Maleate is prescribed for the treatment of:

• Allergic Rhinitis: Provides relief from sneezing, rhinorrhoea, nasal itching, and nasal congestion associated with seasonal and perennial allergies.
• Urticaria and Angioedema: Effectively reduces itching, erythema, and wheal formation in acute and chronic urticarial conditions.
• Common Cold Symptoms: Used as part of combination formulations to relieve runny nose and sneezing associated with upper respiratory tract infections.
• Allergic Conjunctivitis: Alleviates ocular itching, lacrimation, and redness in mild to moderate allergic eye conditions.
• Anaphylactic Reactions: Administered as an adjunctive therapy in emergency management of anaphylaxis following stabilisation with epinephrine.

Why Manufacturers Choose Chlorpheniramine Maleate

Chlorpheniramine Maleate is one of the most widely prescribed first-generation antihistamines globally and continues to see strong demand in both domestic Indian markets and export territories. Its established safety profile over more than seven decades of clinical use, combined with low manufacturing costs and good API stability, makes it a staple product for PCD franchise operators and third-party manufacturers. The molecule is commonly formulated as tablets, syrups, and paediatric drops, offering versatility in production. The consistent prescription volumes from allergy and cold season surges ensure year-round demand, making Chlorpheniramine Maleate third-party manufacturing in India a commercially attractive proposition for WHO-GMP certified facilities.